- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular mechanism of SHP2 activation by PD-1 stimulation
Authors
Keywords
-
Journal
Science Advances
Volume 6, Issue 5, Pages eaay4458
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-02-01
DOI
10.1126/sciadv.aay4458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo
- (2018) Giorgia Rota et al. Cell Reports
- Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
- (2018) Xian Shen et al. BMJ-British Medical Journal
- SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
- (2018) Mingxia Zhao et al. Acta Pharmaceutica Sinica B
- Phosphatases start shedding their stigma of undruggability
- (2018) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2
- (2018) Ricardo A. P. Pádua et al. Nature Communications
- Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
- (2018) Jonathan R. LaRochelle et al. Nature Communications
- Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor
- (2017) Michael Peled et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
- (2016) Ying-Nan P. Chen et al. NATURE
- Nivolumab: targeting PD-1 to bolster antitumor immunity
- (2015) Julie R Brahmer et al. Future Oncology
- Programmed Death-1: Therapeutic Success after More than 100 Years of Cancer Immunotherapy
- (2014) Alexander Dömling et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention
- (2014) Sam Butterworth et al. Future Medicinal Chemistry
- Practical aspects of NMR signal assignment in larger and challenging proteins
- (2013) Dominique P. Frueh PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
- Antagonism between binding site affinity and conformational dynamics tunes alternative cis-interactions within Shp2
- (2013) Jie Sun et al. Nature Communications
- Application of iterative soft thresholding for fast reconstruction of NMR data non-uniformly sampled with multidimensional Poisson Gap scheduling
- (2012) Sven G. Hyberts et al. JOURNAL OF BIOMOLECULAR NMR
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop
- (2012) Nicola Aceto et al. NATURE MEDICINE
- Superbinder SH2 Domains Act as Antagonists of Cell Signaling
- (2012) T. Kaneko et al. Science Signaling
- Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis
- (2012) Shuangwei Li et al. Frontiers of Medicine
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation
- (2011) Wei Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery
- (2010) Latanya M. Scott et al. CURRENT PHARMACEUTICAL DESIGN
- Protein Tyrosine Phosphatases in Autoimmunity
- (2008) Torkel Vang et al. Annual Review of Immunology
- The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway
- (2007) Marie Dance et al. CELLULAR SIGNALLING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More